OR WAIT null SECS
July 02, 2008
With no economic relief in sight, industry, like all of us, is grappling with high-and new-costs.
July 01, 2008
As summer approaches, the European pharmaceutical industry is preparing for a well-deserved break. However, some will leave the arena on a higher note than others. While big pharma is embracing the globalization of the industry and suffering under extreme pressure to improve performance, the biopharmaceutical sector retires with a smile and reasons to celebrate.
June 02, 2008
Risk management, and its benefits for patients, plays a big role at the PDA Annual Meeting.
The good, the bad, and the ugly about direct-to-consumer advertising.
June 01, 2008
On 7–9 May I attended ERBI's Biopartnering Exchange in Cambridge (UK), an event that brought together national and international entrepreneurs, senior executives and industry experts of the biotechnology sector.
May 02, 2008
Scientists are giving up on a preventive vaccine for AIDS, but there are lessons to be learned.
May 01, 2008
One of the headlines before going to print was 'Pfizer earnings suffer as patent expiries cause damage'. This US pharma giant has reported a net income decline of 18% for the first quarter, despite the positive impact of the favourable currency rates.
April 02, 2008
The FDA itself issues a cry for help. Is anybody listening?
April 01, 2008
It is the end of an era. Building on more than 6 years of dedication and hard work, Gurminder Marwaha has left Pharmaceutical Technology Europe (PTE) in search of new challenges. As his successor, I would like to join all the members of the editorial team in wishing him every success.
February 02, 2008
Can an overload of patent applications lead to the US' demise as a scientific leader?